Overview
News
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$43.1M
1 round on record
Latest round
$43.1M
Series B · Aug 2026 · 1 mo ago
Backers
3
BioGeneration Ventures, Epidarex Capital
The money's age
Fresh money
1 months since the last round · not hiring
Momentum
20/100
fresh money
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Aug 7 Raised a round Series B $43.1M · EU-Startups
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Funding rounds
RoundDateAmountInvestorsSource
Series B Aug 2026 $43.1M — EU-Startups
Backed byfrom the funds' portfolios and accelerator catalogs

News

News EU-Startups 2 months ago
Glasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment
Mironid, a Glasgow-based biopharmaceutical company, has closed a €39.9 million ($46 million) Series B financing round to push its lead drug candidate for Autosomal Dominant Polycystic Kidney Disease (ADPKD) through clinical development. The round was led
Read more
Report

Financials

Total raised
$43.1M
Latest round
Series B
Funding rounds
1
Funding rounds
Round Announced Amount
Series B 2026 $43.1M Details